Since both studies provide interesting signals for a potential benefit of local thoracic consolidation, but failed to reach statistical significance within their trial designs, a controversial discussion about who might profit from thoracic radiotherapy is ongoing.
← all excerpts
Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease - a randomized, open-label, multicenter phase II trial.
1
—
—